[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1990

Topical Nonsteroidal Agents and Corneal Wound Healing

Author Affiliations

From the Hilles Immunology Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston (Drs Hersh, Baer, Wells, and Foster and Ms Rice); the Institute of Molecular Biology, Boston (Dr Lynch); and CIBA-GEIGY Pharmaceuticals, Summit, NJ (Dr McGuigan).

Arch Ophthalmol. 1990;108(4):577-583. doi:10.1001/archopht.1990.01070060125062
Abstract

• The effects on corneal wound healing of two topical nonsteroidal anti-inflammatory agents, flurbiprofen sodium (0.03%) and diclofenac sodium (0.1%), and the topical corticosteroid, prednisolone sodium phosphate (1%), were evaluated in masked, controlled rabbit studies. Healing of epithelial scrape wounds was significantly retarded in all three treatment groups for the first 3 days after wounding. There was no difference in the epithelial healing rate between the two nonsteroidal or corticosteroid treatment groups. Clinical grading of epithelial quality, conjunctival hyperemia, keratitis, stromal edema, and corneal haze were similar in all groups. There was a significant early decrease in the iritis score in the diclofenac treatment group. The strength of 2-mm central penetrating corneal trephination wounds and the collagen content of these wounds were similar in all groups. Both the topical nonsteroidal anti-inflammatory agents and the corticosteroid used in the preparations and dosages investigated in this study decreased early epithelialization of scrape wounds but had no apparent effect on corneal stromal healing. No toxic effects of the various drugs were found.

References
1.
Phan TM, Foster CS, Wasson PJ, Fujikawa LS, Zagachin LM, Colvin RB.  Role of fibronectin and fibrinogen in healing of corneal epithelial scrape wounds . Invest Ophthalmol Vis Sci . 1989;30:377-385.
2.
Cintron C, Schneider H, Kublin C.  Corneal scar formation . Exp Eye Res . 1973;17:251-259.Article
3.
McDonald TO, Borgmann AR, Roberts MD, Fox LG.  Corneal wound healing . Invest Ophthalmol Vis Sci . 1970;9:703-709.
4.
Langston RHS, Pavon-Langston D, Dohlman CH.  Antiviral medication and corneal wound healing . Arch Ophthalmol . 1974;92:509-513.Article
5.
Foster CS, Pavon-Langston D.  Corneal wound healing and antiviral medication . Arch Ophthalmol . 1977;95:2062-2067.Article
6.
Switzer BR, Summer GK.  Improved method for hydroxyproline analysis in tissue hydrolysates . Anal Biochem . 1971;39:487-491.Article
7.
McDonald TO, Borgmann AR, Roberts MD, Fox LG.  Corneal wound healing, I: inhibition of stromal healing by three dexamethasone derivatives . Invest Ophthalmol Vis Sci . 1970;9:703-709.
8.
Beams R, Linabery L, Grayson M.  Effect of topical corticosteroids on corneal wound strength . Am J Ophthalmol . 1968:66:1131-1133.
9.
Phillips K, Arffa R, Cintron C, et al.  Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization . Arch Ophthalmol . 1983;101:640-643.Article
10.
Gasset AR, Lorenzetti DWC, Ellison EM, Kaufman HE.  Quantitative corticosteroid effect on corneal wound healing . Arch Ophthalmol . 1969;81:589-591.Article
11.
Ashton N, Cook C.  Effect of cortisone on healing of corneal wounds . Br J Ophthalmol . 1951;35:708-717.Article
12.
Petroutsos G, Guimaraes R, Giraud JP, Pouliquen Y.  Corticosteroids and corneal epithelial wound healing . Br J Ophthalmol . 1982;66:705-708.Article
13.
Srinivasan BD, Kulkarni PS.  The effect of steroidal and nonsteroidal anti-inflammatory agents on corneal re-epithelialization . Invest Ophthalmol Vis Sci . 1981;20:688-691.
14.
Srinivasan BD.  Corneal reepithelialization and anti-inflammatory agents . Trans Am Ophthalmol Soc . 1982;80:758-822.
15.
Sugar A, Bokosky JE, Meyer RF.  A randomized trial of topical corticosteroids in epithelial healing after keratoplasty . Cornea . 1984/ 1985;3:268-271.Article
16.
Gilman AG, Goodman LS, Rall TW, Murad F. Goodman & Gilman's The Pharmacological Basis of Therapeutics . 7th ed. New York, NY: Macmillan Publishing Co Inc; 1985:1463-1489.
17.
Malmsten CL.  Prostaglandins, thromboxanes, and leukotrienes in inflammation . Am J Med 1986;80( (suppl 4B) ):11-16.Article
18.
Brogden RN, Heel RC, Speight TM, Avery GS.  Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases . Drugs . 1979;18:417-438.Article
19.
Ku EC, Lee W, Kothari HV, Scholer DW.  Effect of diclofenac sodium on the arachidonic acid cascade . Am J Med . 1986;80( (suppl 4B) ):18-23.Article
20.
Miller D, Gruenberg P, Miller R, Bergamini MVW.  Topical flurbiprofen or prednisolone: effect on corneal wound healing in rabbits . Arch Ophthalmol . 1981;99:681-682.Article
21.
Kenyon KR.  Inflammatory mechanisms in corneal ulceration . Trans. Am Ophthalmol Soc . 1985;53:610-663.
22.
Srinivasan BD, Kulkarni PS.  Polymorphonuclear leukocyte response: inhibition following corneal epithelial denudation by steroidal and nonsteroidal anti-inflammatory agents . Arch Ophthalmol . 1981;99:1085-1089.Article
23.
Srinivasan BD, Kulkarni PS.  The role of arachidonic acid metabolites in the mediation of the polymorphonuclear leukocyte response following corneal injury . Invest Ophthalmol Vis Sci . 1980;19:1087-1093.
×